Greater Glasgow and Clyde Medicines

Ferric carboxymaltose (Ferinject®▼) and risk of hypophosphataemia - new monitoring requirements.

Key Medicine Shortages for May 2021

The Summary of Product Characteristics was updated in March 2021

This update covers local formulary changes and decisions not related to recent SMC advice such as formulary appeals, new drug assessments and formulary section reviews.

MHRA Drug Safety Update for April 2021

Key Medicine Shortages for April 2021

Management of palliative patients with Parkinson’s disease (PD) approaching end of life who are normally maintained on oral PD medicines

Guideline News for April 2021

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

NHSGGC Palliative Care team is recommending a move to prochlorperazine (displacing oral levomepromazine 6mg tablets) as a second line treatment option for nausea and vomiting in adults in the palliative care setting.